Crossmark

Intranasal fentanyl to reduce pain intensity associated with retinopathy of prematurity screening in preterm infants: study protocol for a randomized controlled trial

Crossref DOI link: https://doi.org/10.1186/s12887-026-07328-x

Published Online: 2026-07-15

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

McCord, Helen https://orcid.org/0009-0003-4002-1770
Disher, Tim

Promelle, Véronique

Mitra, Souvik

Singh, Balpreet

Bruce, Cameron

Peckham, Carmen

Neil, Emily

Campbell-Yeo, Marsha
Funding

Funding for this research was provided by:

IWK Health Centre

Dalhousie University

Canadian Institutes of Health Research
License Information

Text and Data Mining valid from 2026-07-15

Accepted Manuscript valid from 2026-07-15
More Information

Article History

Received: 15 May 2026

Accepted: 8 July 2026

First Online: 15 July 2026

Declarations

Ethics approval and consent to participate: This study has received ethical approval from the IWK Health Research Ethics Board (reference number: 1032049). Written informed consent will be obtained from the parent(s) or legally authorized representative(s) of all participating infants, as described in the Recruitment section.No additional consent is sought for ancillary studies. Biological specimens and participant data will be used only for the purposes described in this protocol and will not be stored or used for future research without separate ethics approval and additional participant consent.

Consent for publication: Not applicable. No individual participant data, images, or videos will be published as part of this study protocol.

Competing interests: The authors declare no competing interests.

Document is current

Any future updates will be listed below